Caplin Point Laboratories Limited

NSE:CAPLIPOINT.NS

1965.5 (INR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 14,667.314,667.312,630.110,482.5758,632.0176,486.9095,398.424,016.4843,084.482,517.6981,730.8891,270.2831,072.166779.212607.071591.187618.926
Cost of Revenue 6,632.16,632.15,604.54,751.0484,164.8862,905.7492,396.2021,932.222,180.8371,356.2031,062.783846.473773.674624.179483.027491.852513.504
Gross Profit 8,035.28,035.27,025.65,731.5274,467.1313,581.163,002.2182,084.264903.6431,161.495668.106423.81298.492155.033124.04499.335105.422
Gross Profit Ratio 0.5480.5480.5560.5470.5180.5520.5560.5190.2930.4610.3860.3340.2780.1990.2040.1680.17
Reseach & Development Expenses 737.2631.9592.7536.947530.143281.862236.814140.88372.46258.82420.86.57600000
General & Administrative Expenses 00228.9166.028103.86650.90325.5734.283239.642201.49912.71310.879042.988042.1638.663
Selling & Marketing Expenses 00275.1180.32428.9648.99340.6240.8750.5371.46714.62610.2306.73104.3434.859
SG&A 1,369.91,062.8504346.352132.8359.89666.1974.283127.029202.966189.995124.763049.719046.50343.522
Other Expenses 669.44,074.52,432.71,914.9391,503.0311.760.712813.817-5.263595.949313.385219.864201.6790.2479.2240.333.656
Operating Expenses 4,074.54,074.53,529.42,798.2382,166.0041,493.6831,238.333958.983204.754654.773334.185219.864201.67984.90879.22468.98693.924
Operating Income 3,960.74,521.33,856.43,138.1972,643.6892,087.4771,763.8851,125.281698.889531.967333.921203.94696.81370.12544.8230.34911.498
Operating Income Ratio 0.270.3080.3050.2990.3060.3220.3270.280.2270.2110.1930.1610.090.090.0740.0510.019
Total Other Income Expenses Net 552.8-7.81.8-2.01250.936181.285119.89892.539101.3571.9222.98717.45714.91112.121-8.3361.7271.641
Income Before Tax 4,513.54,513.53,858.23,136.1852,694.6252,268.7621,883.7831,217.82800.246533.887356.908221.403111.72482.24736.48432.07613.14
Income Before Tax Ratio 0.3080.3080.3050.2990.3120.350.3490.3030.2590.2120.2060.1740.1040.1060.060.0540.021
Income Tax Expense 743.6743.6773.7621.882543.788503.208437.433257.33190.437122.62297.5881.18931.42519.1333.1669.8182.785
Net Income 4,570.83,762.62,998.42,422.72,150.081,765.671,447.877961.585609.752410.369258.486139.83880.06562.82333.31822.25710.355
Net Income Ratio 0.3120.2570.2370.2310.2490.2720.2680.2390.1980.1630.1490.110.0750.0810.0550.0380.017
EPS 49.6249.6239.6132.0328.4223.3519.0612.658.075.433.421.851.060.830.440.290.16
EPS Diluted 49.1849.1839.2631.7128.223.2319.0612.658.075.433.421.851.060.830.440.290.14
EBITDA 5,514.44,971.24,325.43,507.9092,959.8812,451.292,040.5951,352.079798.593619.984393.497219.348109.17993.36665.74750.42636.143
EBITDA Ratio 0.3760.3390.3420.3350.3430.3780.3780.3370.2590.2460.2270.1730.1020.120.1080.0850.058